Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272311 · ClinicalTrials.gov registry record · Phase 4
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
A Phase 4 study of Cardiovascular Diseases and Atherosclerosis, sponsored by Florida Atlantic University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00272311: Completed Phase 4 study of Cardiovascular Diseases and Atherosclerosis, sponsored by Florida Atlantic University.
NCT00272311 is a Phase 4 study of Cardiovascular Diseases and Atherosclerosis that has completed, run by Florida Atlantic University. The registered enrollment target is 70 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00272311, a Phase 4 study of Cardiovascular Diseases and Atherosclerosis, has completed, sponsored by Florida Atlantic University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to test higher versus lower doses of aspirin on markers of atherosclerosis in patients at risk of a first heart attack.
Primary Outcome
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation.
Conditions Studied
Interventions
- DRUG Aspirin
Study Locations (1)
Maryland
- HeartDrug Research, LLC - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-01 |
| Phase | Phase 4 |
What the finished NCT00272311 record still lists
NCT00272311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Aspirin is the first listed.
NCT00272311 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00272311 about?
NCT00272311 is a clinical study titled "Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome". The purpose of the study is to test higher versus lower doses of aspirin on markers of atherosclerosis in patients at risk of a first heart attack.
What is the current status of trial NCT00272311?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2006-10. Estimated completion is 2009-01.
What conditions does trial NCT00272311 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Atherosclerosis, Metabolic Syndrome X.
What interventions are being tested in trial NCT00272311?
The interventions under investigation include: Aspirin (DRUG).
Who is sponsoring clinical trial NCT00272311?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00272311 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00272311's enrollment target sits among peer trials
70 216th of 300 higher than 85 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RECRUITING · Phase 4
-
NSAIDs vs. Coxibs in the Presence of Aspirin
RECRUITING · Phase 4
-
Secondhand Tobacco Smoke and Cardiovascular Disease
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia